Is that an exciting click-bait title or what? It gets even better though. Federal regulations’ hundreds of billions in costs and burdens are a familiar topic. They remain a major component of the ...
On January 6, 2026, the US Food and Drug Administration (FDA) revised its final guidance on Clinical Decision Support ...
A new guidance document issued by the FDA this week offers recommendations for how makers of prescription biosimilars and biologic reference products should approach promotional advertising and ...
FDA has published final guidance documents regarding validation and development of analytical procedures. On March 7, 2024, FDA published two final guidance documents regarding analytical procedures ...
Forbes contributors publish independent expert analyses and insights. Fred L. Smith Jr. Fellow at the Competitive Enterprise Institute. The 2024 Federal Register hit 86,712 pages October 30, the third ...
On January 6, 2025, FDA published two final guidance documents related to food allergens: Questions and Answers Regarding Food Allergens, Including the Food Allergen Labeling Requirements of the ...
“The USPTO’s ‘Apparent Authority’ guidance is a classic case of a rule that has no reason to exist at all. It creates $30 to $40 million per year excess burden on the public because the USPTO skipped ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results